** Jefferies raises price target on specialty chemicals maker Chemours CC.N to $16 from $11

** The new price target represents a ~3% upside to stock's last close

** Brokerage anticipates capacity rationalization to create a titanium dioxide (Tio2) pricing tailwind

** "Productivity gains and mix improvements should still provide some earnings lift, but we think a broad-based cyclical recovery is unlikely until 2026 at the earliest" - brokerage

** Jefferies expects benefit from productivity improvements and optimization efforts to be visible in 2026 and 2027

** 5 of 10 brokerages rate the stock "buy", 4 "hold" and 1 "sell"; median PT is $16.5 - data compiled by LSEG

** As of last close, CC down ~8% YTD

(Reporting by Dharna Bafna in Bengaluru)

((Dharna.bafna@thomsonreuters.com))